Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hummel

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|December 3, 2015
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomasTrent R Hummel, Ralph Salloum, Rachid Drissi, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|November 22, 2020
Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective studyGena Heidary, Michael J Fisher, Grant T Liu, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Discovery of Pyrazolopyridine Derivatives as HPK1 InhibitorsQinda Ye, Kai Liu, Hai-Fen Ye, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
International Journal of Molecular Sciences|May 4, 2026
Molecular and Functional Alterations of P-Glycoprotein in a Genetic Model of Epilepsy: Insights from the Wistar Audiogenic RatRodrigo V Placido, Rafaela F Rodrigues, Lellis H Costa, et al.
Journal of Medicinal Chemistry|April 17, 2026
Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual InhibitorBo Wei, Xiaolei Li, Jacob J Lacharity, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Potent and Selective Biaryl Amide Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)Alexander Sokolsky, Oleg Vechorkin, Joshua R Hummel, et al.
Neuro-Oncology|April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysisMichael J Fisher, Michael Loguidice, David H Gutmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Journal of Neuro-Oncology|October 9, 2020
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)Mariko DeWire, Christine Fuller, Trent R Hummel, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|December 3, 2015
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomasTrent R Hummel, Ralph Salloum, Rachid Drissi, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|November 22, 2020
Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective studyGena Heidary, Michael J Fisher, Grant T Liu, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Discovery of Pyrazolopyridine Derivatives as HPK1 InhibitorsQinda Ye, Kai Liu, Hai-Fen Ye, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
International Journal of Molecular Sciences|May 4, 2026
Molecular and Functional Alterations of P-Glycoprotein in a Genetic Model of Epilepsy: Insights from the Wistar Audiogenic RatRodrigo V Placido, Rafaela F Rodrigues, Lellis H Costa, et al.
Journal of Medicinal Chemistry|April 17, 2026
Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual InhibitorBo Wei, Xiaolei Li, Jacob J Lacharity, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Potent and Selective Biaryl Amide Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)Alexander Sokolsky, Oleg Vechorkin, Joshua R Hummel, et al.
Neuro-Oncology|April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysisMichael J Fisher, Michael Loguidice, David H Gutmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Journal of Neuro-Oncology|October 9, 2020
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)Mariko DeWire, Christine Fuller, Trent R Hummel, et al.
Pageof 11